Pacifichealth Laboratories Stock EBITDA
PacificHealth Laboratories fundamentals help investors to digest information that contributes to PacificHealth Laboratories' financial success or failures. It also enables traders to predict the movement of PacificHealth Pink Sheet. The fundamental analysis module provides a way to measure PacificHealth Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PacificHealth Laboratories pink sheet.
PacificHealth |
PacificHealth Laboratories Company EBITDA Analysis
PacificHealth Laboratories' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current PacificHealth Laboratories EBITDA | (861.23 K) |
Most of PacificHealth Laboratories' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PacificHealth Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, PacificHealth Laboratories reported earnings before interest,tax, depreciation and amortization of (861,233). This is 100.06% lower than that of the Personal Products sector and 100.04% lower than that of the Consumer Staples industry. The ebitda for all United States stocks is 100.02% higher than that of the company.
Did you try this?
Run Economic Indicators Now
Economic IndicatorsTop statistical indicators that provide insights into how an economy is performing |
All Next | Launch Module |
PacificHealth Fundamentals
Return On Equity | -0.75 | ||||
Return On Asset | -0.25 | ||||
Profit Margin | (0.14) % | ||||
Operating Margin | (0.14) % | ||||
Current Valuation | 571.89 K | ||||
Shares Outstanding | 20.87 M | ||||
Price To Earning | (0.34) X | ||||
Price To Book | 0.71 X | ||||
Price To Sales | 0.07 X | ||||
Revenue | 6.91 M | ||||
Gross Profit | 2.99 M | ||||
EBITDA | (861.23 K) | ||||
Net Income | (486.31 K) | ||||
Cash And Equivalents | 324.48 K | ||||
Cash Per Share | 0.02 X | ||||
Total Debt | 54.86 K | ||||
Debt To Equity | 0.07 % | ||||
Current Ratio | 1.58 X | ||||
Book Value Per Share | 0.04 X | ||||
Cash Flow From Operations | (503.96 K) | ||||
Earnings Per Share | (0.04) X | ||||
Target Price | 2.8 | ||||
Beta | -275.06 | ||||
Market Capitalization | 87 | ||||
Total Asset | 1.89 M | ||||
Retained Earnings | (20.59 M) | ||||
Working Capital | 676 K | ||||
Current Asset | 1.84 M | ||||
Current Liabilities | 1.17 M | ||||
Z Score | -11.0 | ||||
Net Asset | 1.89 M |
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Consideration for investing in PacificHealth Pink Sheet
If you are still planning to invest in PacificHealth Laboratories check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PacificHealth Laboratories' history and understand the potential risks before investing.
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |